Anxiety Treatment (Children)
Make it easier for healthcare providers and families to work together to help children overcome anxiety problems with online therapist-supported, parent-led Cognitive Behavior Therapy (OSI) developed by leading experts at the Universities of Reading and Oxford.
An evidence-based, cost-effective way to treat anxiety problems in children
Our Approach
- Simplified care delivery
Clear guidelines and an accessible digital platform empower service providers to provide anxiety treatment with good clinical outcomes
- Satisfied families and providers
NICE EVA recommended online program that makes treatment more efficient and accessible without compromising clinical outcomes or treatment satisfaction
- Engaging and flexible
24/7 access to evidence-based modules make it easy for parents and children to build skills when and where works best for them, saving patients and care providers time
The challenge
Providers with experience treatment anxiety problems are hard to find...and harder to book
While cognitive behavioral therapy (CBT) has been shown to be very effective for anxiety problems in children, a global shortage of therapists means families often face long waits to access treatment.
Finding treatment for anxiety problems designed for children often presents an even greater challenge.
All of the key features of CBT for child anxiety in a convenient digital platform
Weekly 20 minute therapist phone calls for 1:1 support and guidance
Increased flexibility for families with on-demand access to engaging self-study resources and activities
OSI has not been reviewed by the FDA
Koa Perspectives is being developed to provide guided cognitive behavioral therapy (CBT) via app to patients across a range of disorders.
A work in progress, Koa Perspectives is not in commercial distribution in the US and the UK.
Koa Mindset helps individuals better understand and live well with depression by offering cognitive behavioral therapy-based techniques to complement in-person treatment.
Koa Mindset is a wellness device and has not been reviewed or cleared by the FDA.